Sofie Biosciences acquired by GE HealthCare
GE HealthCare agreed to acquire Sofie Biosciences, a US radiopharmaceutical manufacturing brand.
Transaction summary
- Target
- Sofie Biosciences
- Acquirer
- GE HealthCare
- Seller
- -
- Announced
- -
- Geography
- United States
- Tags
- Contract ManufacturingDiagnosticsHealthcareMedtechRadiopharmaceutical ManufacturingRadiopharmaceuticals
- Type
- Acquisition
- Deal type
- Control
- Stake acquired
- -
- First added
- 2026-10-07
- Latest update
- 2026-10-11
Value and multiples
100% enterprise value
USD 945M
100% enterprise value | USD
Basis: Public source
Reported price is assumed to be 100% EV unless stated otherwise. Partial-stake estimates are qualified in the basis notes.
EV / revenue
-
Period not stated
Basis: FundComb estimate
EV / EBITDA
-
EBITDA basis not stated
Basis: FundComb estimate
Amounts paid and other reported values
Original reported amounts and bases; a stake payment is distinct from the estimated whole-company valuation.
Consideration: USD 945M
MedTech Dive reported a $945 million cash acquisition; the specific percentage acquired is not stated.
Basis
- USD 945m enterprise value is treated as publicly disclosed or derived directly from public source data.
- Valuation covers 100% of the target; the amount invested or paid for a stake is separate.
Source summary
GE HealthCare to acquire Sofie Biosciences for $945M
ConfirmedMedTech Dive reported on October 5, 2026 that GE HealthCare agreed to acquire Sofie Biosciences for $945 million in cash, with closing expected in the first half of 2027. The article describes Sofie’s U.S. PET radiopharmaceutical manufacturing and distribution business; it gives no revenue or EBITDA figures.
Open sourceGE HealthCare to acquire Sofie Biosciences for $945M
ConfirmedGE HealthCare to acquire Sofie Biosciences for $945M | BioPharma Dive Skip to main content CONTINUE TO SITE ➞ Don't miss tomorrow's biopharma industry news Let BioPharma Dive's free newsletter keep you informed, straight from your inbox. Daily Dive M-F Commercialization Weekly Every Wednesday Gene Therapy Weekly Every Thursday Emerging Biotech Weekly Every Tuesday By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy . You can unsubscribe at anytime. Informa TechTarget | Healthcare Dive MedTech Dive PharmaVoice Xtelligent Pharma Life Sciences Explore our brands An Informa TechTarget Publication Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search People also ask Loading questions... Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Dive Brief GE HealthCare to acquire Sofie Biosciences for $945M The purchase expands GE HealthCare’s radiopharmaceutical capabilities, helping manufacture and distribute time-sensitive drugs used in PET imaging. Published Oct. 6, 2026 By Susan Kelly Reporter Share Copy link Email LinkedIn X/Twitter Facebook Print License Add us on Google Sofie Biosciences has 15
Open sourceGE HealthCare to acquire Sofie Biosciences for $945M
ConfirmedGE HealthCare to acquire Sofie Biosciences for $945M | MedTech Dive Skip to main content CONTINUE TO SITE ➞ Don't miss tomorrow's medtech industry news Let MedTech Dive's free newsletter keep you informed, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy . You can unsubscribe at anytime. Informa TechTarget | BioPharma Dive Healthcare Dive Xtelligent Health IT Explore our brands An Informa TechTarget Publication Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search People also ask Loading questions... FDA M&A Recalls Earnings Cybersecurity AI Cardiac Diabetes Diagnostics An article from Dive Brief GE HealthCare to acquire Sofie Biosciences for $945M Sofie Biosciences is expected to expand GE HealthCare’s footprint in the radiopharmaceutical industry, helping manufacture and distribute time-sensitive drugs used in PET imaging. Published Oct. 5, 2026 By Susan Kelly Reporter Share Copy link Email LinkedIn X/Twitter Facebook Print License Add us on Google Sofie Biosciences has 15 CMO sites across the U.S. manufacturing PET radiopharmaceutical products. Courtesy of GE HealthCare Listen to the articl
Open source